Covered recipient · General Payments record
GARY T ANDERSON
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$533.61
- Reported across 35 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $149.43 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| AIMMUNE THERAPEUTICS, INC. | $29.03 | 2 |
| Tempus AI, Inc | $23.78 | 1 |
| Xeris Pharmaceuticals, Inc. | $20.19 | 1 |
| ABBVIE INC. | $19.33 | 1 |
| Acerta Pharma LLC | $15.26 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $15.17 | 1 |
| Gilead Sciences, Inc. | $13.47 | 1 |
| PFIZER INC. | $13.20 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.33 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106439575 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $15.61 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146985185 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $13.42 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147012158 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.26 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105682435 | CMS |
| Gilead Sciences, Inc. | $13.47 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133709821 | CMS |
| Novartis Pharmaceuticals Corporation | $15.17 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086650007 | CMS |
| PFIZER INC. | $13.20 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131945174 | CMS |
| Tempus AI, Inc | $23.78 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150178129 | CMS |
| Xeris Pharmaceuticals, Inc. | $20.19 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144626441 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.